ebi-pharm ag - Luffa comp.-Heel, Nasenspray | | 52492 | | 01 | | Luffa comp.-Heel | | Nasenspray | | R01Z | | Rhinologika, Homöopathika | | 07.01.1994 | | |
| Composition | histaminum (Ph.Eur.Hom.) D12 (HAB 5a) 50 mg, histaminum (Ph.Eur.Hom.) D30 (HAB 5a) 50 mg, histaminum (Ph.Eur.Hom.) D200 (HAB 5a) 50 mg, luffa operculata (HAB) D4 100 mg, luffa operculata (HAB) D12 100 mg, luffa operculata (HAB) D30 100 mg, sulfur (HAB) D12 (HAB SV) 50 mg, sulfur (HAB) D30 (HAB SV) 50 mg, sulfur (HAB) D200 (HAB SV) 50 mg, thryallis glauca (HAB) D4 100 mg, thryallis glauca (HAB) D12 100 mg, thryallis glauca (HAB) D30 100 mg, benzalkonii chloridi solutio corresp. benzalkonii chloridum 0.09-0.11 mg, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, natrii chloridum, aqua purificata, ad solutionem pro 1 ml, corresp. 8 doses. | Packungsbestandteile | | Spray nasale | | | | Principe actif | Concentr. |
---|
| 50 mg/ml | | 100 mg/ml | | 50 mg/ml | | 100 mg/ml |
| | Agents auxilliaires | Concentr. |
---|
Aqua Purificata | | | | Disodium Phosphate Dihydrate | | | 50 mg/ml | | 50 mg/ml | | 100 mg/ml | | 100 mg/ml | Sodium Chlorure | | Sodium Dihydrogenophosphate Dihydrate | | | 50 mg/ml | | 50 mg/ml | | 100 mg/ml | | 100 mg/ml |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
017 | 20 ml | DDP | DDP | D | | Non |
|
|